88 Directors Report | Board of Directors 01 02 03 05 06 07 09 10 11 01 Louis Schweitzer 67 02 David Brennan 56 Non-Executive Chairman, Chairman of the Executive Director and Chief Executive Officer Board of Directors Nomination and Governance Committee Appointed as a Director 14 March 2005 and and Remuneration Committee Member as CEO 1 January 2006.
Chairman of the at 31 December Appointed as a Director 11 March 2004 and as Executive Board of the Pharmaceutical Chairman 1 January 2005.
Non-Executive Research and Manufacturers of America Chairman of Renault SA 2005-2009.
Vice-President of the International and Chief Executive Officer of Renault SA Federation of Pharmaceutical Manufacturers 1992-2005.
Non-Executive Director of and Associations IFPMA.
Board Member of BNP-Paribas, Veolia Environnement SA the European Federation of Pharmaceutical senior Non-Executive Director and LOral Industries and Associations EFPIA.
Non-Executive Chairman of Volvo AB Commissioner of the UK Commission for and Journal Le Monde SA.
Chairman of the Board of the Southeastern Pennsylvania Chapter of the American Heart Association 2004-2006.
Otherofficers of the Company at 31 December included members of the SET, as set out in the Senior Executive Team at 31 December section from page 90 and Adrian Kemp, Company Secretary appointed on 1 January 2009.
AstraZeneca Annual Report and Form 20-F Information 2009 Directors Report | Board of Directors 89 Corporate Governance 05 Bo Angelin 60 09 Rudy Markham 63 Non-Executive Director and Non-Executive Director and Science Committee Member Audit Committee Member Appointed as a Director 24 July 2007.
Professor of Clinical Metabolism at Karolinska Chairman and Non-Executive Director of Institutet and Head of the Department of Moorfields Eye Hospital Foundation Trust.
Endocrinology, Metabolism and Diabetes Non-Executive Director of United Parcel at the Karolinska University Hospital in Services Inc. Financial Reporting Council, Stockholm, Sweden.
Member of the Nobel Standard Chartered PLC and Legal & General Assembly and of the Swedish Royal Academy plc.
Non-Executive member of the Board of of Sciences.
Member of the Medical Nobel the UK Foreign and Commonwealth Office.
Prior appointments include Fellow of the Chartered Institute of Chairman of the Nobel Committee for Management Accountants and Fellow of Physiology and Medicine.
the Association of Corporate Treasurers.
06 John Buchanan 66 10 Dame Nancy Rothwell 54 Non-Executive Director, Chairman of Non-Executive Director, Chairman of the the Audit Committee and Remuneration Science Committee and Remuneration Committee Member Committee Member Appointed as a Director 25 April 2002.
Also Executive Director and Group Chief Financial has responsibility for overseeing Corporate Officer of BP p. l. c. 1996-2002.
MRC Research Professor and UK Accounting Standards Board 1997-2001.
Deputy President and Deputy Vice-Chancellor Senior Independent Director of BHP Billiton at the University of Manchester.
Senior Independent Director and Deputy and Council member of the Royal Society: Chairman of Vodafone Group Plc.
Chairman of President of the Society of Biology.
Chairman of International appointments include: Trustee of Cancer Chamber of Commerce UK.
Member of the Research UK and the Campaign for Medical Advisory Board of Ondra Bank.
Progress: Chair of the Research Defence Society: Chair of the Wellcome Trust Public 07 Jean-Philippe Courtois 49 Engagement Strategy Panel: President of Non-Executive Director and the British Neuroscience Association: and Audit Committee Member Council member of the Medical Research Appointed as a Director 18 February 2008.
Council and the Biotechnology and President, Microsoft International and Senior Biological Sciences Research Council.
President 11 John Varley 53 Microsoft EMEA 2000-2003.
Corporate Non-Executive Director, Chairman of the Vice-President, Microsoft Worldwide Remuneration Committee and Nomination and Governance Committee Member Customer Marketing 1998-2000.
Administrator Appointed as a Director 26 July 2006. for PlaNet Finance and representative at the 03 Simon Lowth 48 Executive Director of Barclays Bank plc and Institut Montaigne.
Executive Director and Chief Financial Officer Barclays plc since 1998 and Group Chief Appointed as a Director and as CFO Executive since 2004.
Chairman of Business 08 Jane Henney 62 5 November 2007.
Director of Finance and Non-Executive Director, Audit Committee Action on Homelessness and President of the Strategy, Scottish Power plc ScottishPower Member, Nomination and Governance Committee Employers Forum on Disability and member Member and Science Committee Member 2005-2007 and Executive Director, Corporate of the International Advisory Panel of the Appointed as a Director 24 September 2001.
Strategy and Development, ScottishPower Monetary Authority of Singapore.
Honorary Currently Professor of Medicine, University of 2003-2005.
Director Head of UK Industrial President of the UK Drug Policy Commission.
Prior appointments include: Senior Practice, McKinsey & Company 2000-2003.
Treasurer and Trustee of St. Dunstans and Vice-President and Provost for Health Affairs, Effective from 1 May 2010, Non-Executive Trustee of Thornton Smith & Plevins Young University of Cincinnati Academic Health Director of Standard Chartered PLC.
Center: Commissioner of Food and Drugs, FDA: Vice-President for Health Sciences, 04 Michele Hooper 58 12 Marcus Wallenberg 53 Senior independent Non-Executive Director, University of New Mexico: Deputy Non-Executive Director Audit Committee Member and Nomination Commissioner for Operations, FDA: Appointed as a Director 6 April 1999.
Formerly and Governance Committee Member Vice-Chancellor for Health Programs and a Director of Astra AB appointed 18 May 1989.
Appointed as a Director 1 July 2003 and as Policy, University of Kansas: Deputy Director, Chairman of Skandinaviska Enskilda Banken senior independent Non-Executive Director US National Cancer Institute.
Non-Executive AB, Electrolux AB and Saab AB.
President and Chief Executive Director of AmerisourceBergen Corporation Chairman of Telefonaktiebolaget L M Ericsson Officer, Directors Council.
President and Chief and CIGNA Corporation.
Non-Executive Director of Stora Enso Executive Officer, Stadtlander Drug Company appointments include The Commonwealth Oyj and the Knut and Alice Wallenberg 1998-1999.
Corporate Vice-President and Fund and China Medical Board.
Board member of Temasek President, International Businesses of Holdings Private Limited.
Honorary Chairman Caremark International Inc. 1992-1998. of International Chamber of Commerce.
Non-Executive Director of UnitedHealth Group Inc. PPG Industries, Inc. and Warner Music Group, Inc. AstraZeneca Annual Report and Form 20-F Information 2009 AstraZeneca Annual Report and Form 20-F Information 2009
